STOCK TITAN
  1. Home
  2. News
  3. SLGC
  4. Boston Millennia Partners Intends to Vote Against Proposed Merger of SomaLogic With Standard BioTools

Boston Millennia Partners Intends to Vote Against Proposed Merger of SomaLogic With Standard BioTools

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
acquisition

BOSTON--(BUSINESS WIRE)-- Boston Millennia Partners (“Boston Millennia”), a significant shareholder of SomaLogic (the “Company”) (Nasdaq: SLGC) today announced that it intends to vote against the Company’s planned merger (the “Merger”) with Standard BioTools Inc. (Nasdaq: LAB).

Amy Merk

amy@bmpvc.com

Source: Boston Millennia Partners

Stock SLGC logo
Somalogic, Inc.

NASDAQ:SLGC

SLGC Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

SLGC Latest News

Mar 5, 2024
OncoHost Selected to Present in Oral Minisymposium at American Association of Cancer Research (AACR) Annual Meeting 2024
Jan 4, 2024
SomaLogic Stockholders Vote to Approve Standard BioTools Transaction at Special Meeting
Jan 4, 2024
Madryn Asset Management Demands SomaLogic’s Board Address Repeated, Unprecedented Adjournments of Tainted Special Meeting
Jan 4, 2024
Madryn Asset Management Addresses SomaLogic’s Apparent Failure to Obtain Requisite Shareholder Support for the Proposed Merger with Standard BioTools
Jan 2, 2024
SomaLogic Urges Stockholders to Maximize Value of Their Investment by Voting "FOR" Pending Merger with Standard BioTools

SLGC Stock Data

396.23M
175.53M
2.16%
61.71%
3.79%
Health Information Services
Healthcare
Link
United States
Boulder